aminophylline has been researched along with Ductus Arteriosus, Patent in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, T; He, Y; Li, C; Liang, J; Liang, L; Luo, F; Shen, Q; Tang, C; Wang, S; Xu, F; Yang, J; Yang, T | 1 |
| Charpie, JR; Crowley, DC; Kim, DW; Kulik, TJ; Lim, DS; Maher, KO | 1 |
1 trial(s) available for aminophylline and Ductus Arteriosus, Patent
| Article | Year |
|---|---|
Aminophylline for the prevention of apnea during prostaglandin E1 infusion.
Topics: Alprostadil; Aminophylline; Apnea; Bradycardia; Bronchodilator Agents; Double-Blind Method; Ductus Arteriosus, Patent; Humans; Hypnotics and Sedatives; Hypoxia; Infant, Newborn; Intubation, Intratracheal; Irritable Mood; Length of Stay; Palliative Care; Prospective Studies; Survival Rate; Treatment Outcome | 2003 |
1 other study(ies) available for aminophylline and Ductus Arteriosus, Patent
| Article | Year |
|---|---|
Risk factors that affect the degree of bronchopulmonary dysplasia in very preterm infants: a 5-year retrospective study.
Topics: Adult; Aminophylline; Birth Weight; Bronchopulmonary Dysplasia; Caffeine; Ductus Arteriosus, Patent; Female; Fetal Growth Retardation; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Retrospective Studies; Risk Factors | 2022 |